Last reviewed · How we verify
V0034 CR
V0034 CR is a small molecule drug that targets the molecular target.
V0034 CR is a small molecule drug that targets the molecular target. Used for unknown.
At a glance
| Generic name | V0034 CR |
|---|---|
| Sponsor | Orfagen |
| Drug class | small molecule |
| Target | unknown |
| Modality | Small molecule |
| Therapeutic area | unknown |
| Phase | Phase 3 |
Mechanism of action
It works by binding to the molecular target, which leads to the desired therapeutic effect. This mechanism is still being researched and more information is needed to fully understand how it works.
Approved indications
- unknown
Common side effects
- unknown
Key clinical trials
- Long-term Efficacy and Safety of V0034 CR 01B Cream in Patients With Moderate-to-severe Uremic Xerosis (PHASE3)
- Efficacy, Local Tolerance and Patient Acceptability of a Moisturizing Emollient in Patients With Uremic Xerosis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |